Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Julphar
McKinsey
Mallinckrodt
AstraZeneca
Healthtrust
Daiichi Sankyo
Medtronic
Harvard Business School

Generated: July 17, 2018

DrugPatentWatch Database Preview

Oxymetazoline hydrochloride; tetracaine hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for oxymetazoline hydrochloride; tetracaine hydrochloride and what is the scope of oxymetazoline hydrochloride; tetracaine hydrochloride patent protection?

Oxymetazoline hydrochloride; tetracaine hydrochloride
is the generic ingredient in one branded drug marketed by St Renatus and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Oxymetazoline hydrochloride; tetracaine hydrochloride has twenty-three patent family members in thirteen countries.

There are three drug master file entries for oxymetazoline hydrochloride; tetracaine hydrochloride. One supplier is listed for this compound.
Summary for oxymetazoline hydrochloride; tetracaine hydrochloride
International Patents:23
US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 3
Suppliers / Packagers: 1
Clinical Trials: 5
DailyMed Link:oxymetazoline hydrochloride; tetracaine hydrochloride at DailyMed
Pharmacology for oxymetazoline hydrochloride; tetracaine hydrochloride

US Patents and Regulatory Information for oxymetazoline hydrochloride; tetracaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
St Renatus KOVANAZE oxymetazoline hydrochloride; tetracaine hydrochloride SPRAY, METERED;NASAL 208032-001 Jun 29, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
St Renatus KOVANAZE oxymetazoline hydrochloride; tetracaine hydrochloride SPRAY, METERED;NASAL 208032-001 Jun 29, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
St Renatus KOVANAZE oxymetazoline hydrochloride; tetracaine hydrochloride SPRAY, METERED;NASAL 208032-001 Jun 29, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
St Renatus KOVANAZE oxymetazoline hydrochloride; tetracaine hydrochloride SPRAY, METERED;NASAL 208032-001 Jun 29, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for oxymetazoline hydrochloride; tetracaine hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,855,247 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
QuintilesIMS
Accenture
Teva
Cantor Fitzgerald
Chinese Patent Office
Fuji
McKesson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.